Clinical Trial Update: Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating pramipexole and bromocriptine on nonmotor symptoms in early Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Bromocriptine (bromocriptine)
• Pramipexole (pramipexole)

Snippet

Sponsor: Sandoz | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED